menu
European Commission
This project has received funding from the
European Union’s Seventh Framework Programme
for research, technological development and demonstration.
agence de communication Lyon
menu

    TumAdoR PROJECT

    Developing New Therapeutic Monoclonal Antibodies to neutralize Adenosine immunosuppressive pathway in tumour context

    Based on the broad immuno-suppression and strong tumour promotion (proliferation and dissemination) exerted by Adenosine, therapeutic strategies aimed at inhibiting Adenosine are highly promising

    Events
    News

    17 January 2017 M42 meeting in Diablerets

    LICR Partner proposed to organized the coming M42 meeting in the region of Lausanne for a change. Partners will meet on 10th and 11th of March in Diablerets.More >>


    17 May 2016 M36 meeting in Brussels

    To allow presentation of project results and direct interaction with our Project Officer, TumAdoR consortium will organize its M36 biannual meeting in Brussels.More >>


    Displaying results 3 to 4 out of 8
    Brochure